Powered by: Motilal Oswal
Menu
Close X
Nippon India Pharma Fund(G)

Scheme Returns

5.72%

Category Returns

2.8%

Riskometer

  • Low
  • Low to moderate
  • Moderate
  • Moderately High
  • High
  • Very High

NAV Chart

Trailing Returns

1 Day 1 week 1 Mth 3 Mth 1 Yrs 3 Yrs 4 Yrs 5 Yrs Since Inception
Nippon India Pharma Fund(G) -0.44 0.56 5.72 -0.51 13.51 24.12 16.82 15.57 19.84
Equity - Sectoral Fund - Pharma & Health Care -1.31 -2.12 2.80 -2.79 15.88 21.43 18.90 17.80 16.53

* Equity - Returns upto 1 year are absolute and over 1 year are CAGR.

* Debt - Returns upto 1 year are annualized and over 1 year are CAGR.

  • AMC

    Nippon Life India Asset Management Limited

  • Fund

    Nippon India Mutual Fund

Snapshot

  • Inception Date

    05-Jun-2004

  • Initial Price

    ₹10

  • Entry Load

    --

  • Size of Fund(in Cr.)

    451,077.39

  • Scheme Plan

    --

  • Scheme Class

    Equity - Sectoral Fund - Pharma & Health Care

  • Objectives

    The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

  • Scheme Type

    Open ended scheme

  • Min. Investment

    ₹5,000

  • Exit Load

    1

  • Latest NAV

    512.8559

  • Fund Manager

    Mr. Sailesh Raj Bhan

  • Fund Manager Profile

    Sailesh has Over 10 years experience in Equity Securities research and analysis. he is in Reliance Capital Asset Management Limited as managing various Schemes of Reliance Mutual Fund From 2003 to till date

  • Fund Information

  • AMC

    Nippon Life India Asset Management Limited

  • Address

    4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W) Mumbai - 400 013

  • Phone

    022-68087000

  • Fax

    022-68087097

  • Email

    customercare@nipponindiaim.in

  • Website

    https://mf.nipponindiaim.com/

  • Registrar Agent

  • Registrar

    KFin Technologies Limited

  • Address

    301, Centrium, 3rd Floor, 57, L.B.S. Road Nav Pada, Kurla (West) Mumbai - 400070

  • Phone

    022 - 4617 0911

  • Fax

  • Email

    investorsupport.mfs@kfintech.com

  • Website

    https://mfs.kfintech.com/

Portfolio Details

Allocation
Equity : 98.97
Others : 1.03

Companies - Holding Percentage

Company Market Value hold percentage
Sun Pharmaceutical Industries Limited 99807.54 12.67
Lupin Limited 62086.56 7.88
Divi's Laboratories Limited 51479.12 6.54
Dr. Reddy's Laboratories Limited 47701.7 6.06
Cipla Limited 46274.51 5.88
Apollo Hospitals Enterprise Limited 45159.38 5.73
MedPlus Health Services Limited 28980.13 3.68
Vijaya Diagnostic Centre Limited 27674.64 3.51
Ajanta Pharma Limited 26687.41 3.39
GlaxoSmithKline Pharmaceuticals Limited 21932.04 2.78
Sai Life Sciences Limited 21344.3 2.71
Aurobindo Pharma Limited 20562.66 2.61
Abbott India Limited 20449.65 2.6
IPCA Laboratories Limited 20072.63 2.55
Mankind Pharma Limited 19267.95 2.45
JB Chemicals & Pharmaceuticals Limited 18688.44 2.37
Thyrocare Technologies Limited 18446.9 2.34
Alkem Laboratories Limited 18376.82 2.33
Dr. Lal Path Labs Limited 17170.87 2.18
Narayana Hrudayalaya Limited 16333.82 2.07
Gland Pharma Limited 14782.94 1.88
Pfizer Limited 14523.61 1.84
Max Healthcare Institute Limited 11877.14 1.51
Emcure Pharmaceuticals Limited 10924.88 1.39
Suraksha Diagnostic Limited 10362.34 1.32
Fortis Healthcare Limited 9399.61 1.19
Sanofi India Limited 9251.64 1.17
Triparty Repo 9081.67 1.15
Sanofi Consumer Healthcare India Limited 9073.67 1.15
Syngene International Limited 8916.82 1.13
Biocon Limited 8140.66 1.03
Akums Drugs and Pharmaceuticals Limited 6660.34 0.85
Anthem Biosciences Limited 6343.61 0.81
AstraZeneca Pharma India Limited 5349.56 0.68
Indoco Remedies Limited 3991.14 0.51
Concord Biotech Limited 1313.14 0.17
Cash Margin - CCIL 6.51 0
Net Current Assets -955.9 -0.12

Sectors - Holding Percentage

Sector hold percentage
Healthcare 94.16%
Retailing 3.68%
Miscellaneous 1.15%
Business Services 1.13%

Divident Details

Scheme Name Date Dividend (%)
No Data Found

Alternative Funds From Category

Scheme Name Asset Size 1M 3M 6M 1Y 3Y
HDFC Pharma and Healthcare Fund - Growth Option 506.59 7.71 0.95 3.66 20.97 0
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth 102.69 6.81 -1.4 0.51 18.39 0
Mirae Asset Healthcare Fund -Regular Growth 1583.14 8.28 1.33 2.46 16.65 25.1
Kotak Healthcare Fund - Regular Plan - Growth Option 214.38 7.91 0.95 2.54 15.65 0
PGIM India Healthcare Fund - Regular Plan - Growth Option 109.73 7.86 0.1 2.35 14.78 0
UTI Healthcare Fund - Regular Plan - Growth Option 5.42 4.32 -2.4 -2.15 13.76 25.62
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth 453.42 5.39 0.45 0.71 13.58 24.09
Nippon India Pharma Fund-Growth Plan-Growth 4510.77 5.72 -0.51 0.87 13.51 24.12
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 2552.23 3.07 -4.89 -3.26 13.25 27.7
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 512.42 5.17 -2.53 -1.82 12.56 24.04

Other Funds From - Nippon India Pharma Fund(G)

Scheme Name Asset Size 1M 3M 6M 1Y 3Y
Nippon India Small Cap Fund - Growth Plan - Growth Option 68969.15 1.33 -5.03 -4.78 14.31 20.28
Nippon India Small Cap Fund - Growth Plan - Growth Option 68571.85 1.33 -5.03 -4.78 14.31 20.28
Nippon India Small Cap Fund - Growth Plan - Growth Option 68287.15 1.33 -5.03 -4.78 14.31 20.28
Nippon India Small Cap Fund - Growth Plan - Growth Option 66601.8 1.33 -5.03 -4.78 14.31 20.28
Nippon India Small Cap Fund - Growth Plan - Growth Option 66136.11 1.33 -5.03 -4.78 14.31 20.28
Nippon India Small Cap Fund - Growth Plan - Growth Option 65922 1.33 -5.03 -4.78 14.31 20.28
Nippon India Small Cap Fund - Growth Plan - Growth Option 65812.16 1.33 -5.03 -4.78 14.31 20.28
Nippon India Small Cap Fund - Growth Plan - Growth Option 64821.04 1.33 -5.03 -4.78 14.31 20.28
Nippon India Small Cap Fund - Growth Plan - Growth Option 63006.73 1.33 -5.03 -4.78 14.31 20.28
Nippon India Small Cap Fund - Growth Plan - Growth Option 62259.56 1.33 -5.03 -4.78 14.31 20.28